In today’s recent session, 3.35 million shares of the Staar Surgical Co (NASDAQ:STAA) have been traded, and its beta is 0.62. Most recently the company’s share price was $15.81, and it changed around -$6.07 or -27.75% from the last close, which brings the market valuation of the company to $778.98M. STAA at last check was trading at a discount to its 52-week high of $52.68, offering almost -233.21% off that amount. The share price’s 52-week low was $21.13, which indicates that the recent value has fallen by an impressive -33.65% since then. We note from Staar Surgical Co’s average daily trading volume that its 10-day average is 0.48 million shares, with the 3-month average coming to 606.87K.
Staar Surgical Co stock received a consensus recommendation rating of Buy, based on a mean score of 2.20. If we narrow it down even further, the data shows that 1 out of 13 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 5 recommended STAA as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight. Staar Surgical Co is expected to report earnings per share of -0.5 for the current quarter.
Staar Surgical Co (NASDAQ:STAA) trade information
Instantly STAA has been showing red trend so far today with a performance of -27.75% on intraday trading today. The performance over the last five days has remained in the red territory. The rise to weekly highs of 23.79 on recent trading dayincreased the stock’s daily price by 33.54%. The company’s shares are currently down -34.92% year-to-date, but still down -33.10% over the last five days. On the other hand, Staar Surgical Co (NASDAQ:STAA) is -29.68% down in the 30-day period. We can see from the shorts that 3.94 million shares have been sold at a short interest cover period of 5.67 day(s).
The consensus price target as assigned by Wall Street analysts is $48, which translates to bulls needing to increase their stock price by 67.06% from its current value. Analyst projections state that STAA is forecast to be at a low of $45.03 and a high of $85.
Staar Surgical Co (STAA) estimates and forecasts
The year-over-year growth rate is expected to be -12.61%, down from the previous year.
Consensus estimates provided by 8 financial analysts predict the company will bring in an average of 45.7M in revenue for the current quarter. 8 analysts expect Staar Surgical Co to make 50.1M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 77.36M and 99M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -40.92%. Forecasts for the next quarter put sales growth at -49.39%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 31.51%. Staar Surgical Co earnings are expected to increase by 284.52% in 2025, but the outlook is positive 96.51% per year for the next five years.
STAA Dividends
Staar Surgical Co’s next quarterly earnings report is expected to be released in March.
Staar Surgical Co (NASDAQ:STAA)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 0.52% of Staar Surgical Co shares, and 100.36% of them are in the hands of institutional investors. The stock currently has a share float of 100.89%. Staar Surgical Co stock is held by 313.0 institutions, with BROADWOOD CAPITAL INC being the largest institutional investor. By 2024-06-30, it held 22.0182% of the shares, which is about 10.77 million shares worth $512.68 million.
BLACKROCK INC., with 15.3123% or 7.49 million shares worth $356.54 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
iShares Core S&P Smallcap ETF and Vanguard Total Stock Market Index Fund were the top two Mutual Funds as of Nov 30, 2024. The former held 3.18 shares worth $50.57 million, making up 6.45% of all outstanding shares. On the other hand, Vanguard Total Stock Market Index Fund held roughly 1.56 shares worth around $24.77 million, which represents about 3.16% of the total shares outstanding.
